Regression term
|
CSF cystathionine
|
CSF SAH
|
CSF 5-MTHF
|
Plasma Hcy
|
---|
CSF p-tau181
|
Intercept
|
1.0719a
|
1.0503a
|
2.1744a
|
1.1802a
|
Age
|
0.0063b
|
0.0038
|
0.0045c
|
0.0054c
|
Sexd
|
−0.0279
|
−0.0223
|
−0.0140
|
−0.0236
|
APOE ε4 genotypee
|
0.0328
|
0.0195
|
0.0362
|
0.0314
|
CDR categoryf
|
0.1173b
|
0.1182b
|
0.1110b
|
0.1186b
|
Biomarker
|
0.1120
|
0.3195b
|
−0.4965a
|
0.1670
|
CSF tau
|
Intercept
| |
1.4134a
|
2.8174a
| |
Age
| |
0.0073c
|
0.0080c
| |
Sexd
| |
−0.0215
|
−0.0108
| |
APOE ε4 genotypee
| |
0.0692
|
0.0894
| |
CDR categoryf
| |
0.1758a
|
0.1665b
| |
Biomarker
| |
0.3803b
|
−0.6269a
| |
-
Abbreviations: Aβ β-Amyloid, APOE Apolipoprotein E, CDR Clinical Dementia Rating, CSF Cerebrospinal fluid, Hcy Homocysteine, 5-MTHF 5-Methyltetrahydrofolate, p-tau181 Tau phosphorylated at threonine 181, SAH S-adenosyl-L-homocysteine
- Values of the regression terms are reported, and their differences from 0 were assessed with a t test
-
a
p ≤ 0.001
-
b
p ≤ 0.01
-
c
p ≤ 0.05
-
dFemales (versus reference males)
-
e
APOE ε4 carriers (versus reference noncarriers)
-
f CDR >0 (versus reference CDR 0)